Literature DB >> 17581944

A midlife stroke surge among women in the United States.

Amytis Towfighi1, Jeffrey L Saver, Rita Engelhardt, Bruce Ovbiagele.   

Abstract

BACKGROUND: We assessed sex differences in stroke prevalence among individuals of midlife age (35 to 64 years) in the United States and determined factors predicting stroke.
METHODS: Data from 1999 to 2004 (n = 17,061) from the National Health and Nutrition Examination Survey, a nationally representative sample of US adults, were used to assess sex differences in stroke prevalence and to identify independent predictors of stroke occurrence among middle-aged individuals.
RESULTS: Women aged 45 to 54 years had significantly higher odds of having experienced a stroke vs men of the same age (odds ratio [OR] 2.39, 95% CI 1.32 to 4.32). No other significant midlife stroke differences between sexes were noted. A higher stroke trend was seen in 45- to 54-year-old women vs 35- to 44-year-old women (OR 2.13, 95% CI 0.95 to 4.80, p = 0.067), but no difference was seen in stroke rates in 55- to 64-year-old women vs 45- to 54-year-old women (OR 1.40, 95% CI 0.6912 to 2.8229, p = 0.352). Independent predictors of stroke in women aged 45 to 54 years were coronary artery disease (OR 12.790, 95% CI 1.901 to 86.063, p = 0.009) and waist circumference (OR 1.543, 95% CI 1.002 to 2.376, p = 0.049). Several vascular risk factors including systolic blood pressure and total cholesterol levels increased at higher rates among women compared with men in each successively older cohort from 35 to 64 years.
CONCLUSIONS: A higher prevalence of stroke may exist among women aged 45 to 54 years compared with similarly aged men. This potential disparity could be due in part to inadequate stroke risk factor modification in women and is deserving of further study.

Entities:  

Mesh:

Year:  2007        PMID: 17581944     DOI: 10.1212/01.wnl.0000268491.89956.c2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  54 in total

1.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 2.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

3.  Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats.

Authors:  M De Butte-Smith; R S Zukin; A M Etgen
Journal:  Brain Res       Date:  2012-07-04       Impact factor: 3.252

4.  Gender differences in stroke incidence and poststroke disability in the Framingham heart study.

Authors:  Rodica E Petrea; Alexa S Beiser; Sudha Seshadri; Margaret Kelly-Hayes; Carlos S Kase; Philip A Wolf
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

5.  Effects of Estrogen and Phytoestrogen Treatment on an In Vitro Model of Recurrent Stroke on HT22 Neuronal Cell Line.

Authors:  Javier Morán; Marcos Perez-Basterrechea; Pablo Garrido; Elena Díaz; Ana Alonso; Jesús Otero; Enrique Colado; Celestino González
Journal:  Cell Mol Neurobiol       Date:  2016-04-08       Impact factor: 5.046

Review 6.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

Review 7.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

8.  Buyang Huanwu Decoction () reduces infarct volume and enhances estradiol and estradiol receptor concentration in ovariectomized rats after middle cerebral artery occlusion.

Authors:  Bai-yan Liu; Xiao-ling Song; Jian Yi; Xue-mei Chen; Yue Yu; Hui Liu; Guang-xian Cai
Journal:  Chin J Integr Med       Date:  2014-08-07       Impact factor: 1.978

Review 9.  Interactions between age, sex, and hormones in experimental ischemic stroke.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Neurochem Int       Date:  2012-10-13       Impact factor: 3.921

10.  Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  Neurobiol Aging       Date:  2008-09-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.